Reuters logo
BRIEF-Wave Life Sciences reports Q4 net loss of $18.5 million
2017年3月16日 / 中午12点28分 / 8 个月前

BRIEF-Wave Life Sciences reports Q4 net loss of $18.5 million

March 16 (Reuters) - Wave Life Sciences Ltd

* Wave Life Sciences reports fourth quarter and full-year 2016 financial results and provides business update

* Wave ended 2016 with $150.3 million in cash and cash equivalents compared to $161.2 million as of December 31, 2015

* Expects capital resources available as of Dec. 31, 2016 will fund operating expenses and capital expenditure requirements into 2019

* Says both WVE-120101 and WVE-120102 are expected to enter clinical trials in mid-2017

* Is on track to deliver six development programs by end of 2018

* Reported a net loss of $18.5 million in Q4 of 2016 compared to $7.1 million in Q4 of 2015 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below